HOFJF yields 1.45% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, HOFJF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HOFJF + PFE for your $10,000?
House Foods Group Inc. engages in the manufacture, sale, import, and export of spices, seasonings, processed foods, and commercial use food products in Japan and internationally. It operates through Spice/Seasoning/Processed Food Business, Health Food Business, Restaurant Business, International Food Business, and Other Food Related Business segments. The company offers curry, stew, starch, processed meat, retort pouched food products, etc.; condiments, such as curry roux products; soy-bean products, prepared dishes, baked breads, dessert products, and beverages; health food products through mail-order; and frozen vegetables, mustard essential oils, processed foods, etc. It also conducts agricultural management; processes and sells agricultural products; provides safety and sanitation analysis for food products; and operates and transport and warehouses. In addition, the company is involved in the restaurant operations guidance and trading services; and marketing of vegetables. It operates 1,259 restaurants in Japan and 202 restaurants internationally under the Ichibanya name. The company was formerly known as House Foods Corp and changed its name to House Foods Group Inc. in 2013. House Foods Group Inc. was founded in 1913 and is headquartered in Tokyo, Japan.
Full HOFJF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.